“Synthesis, antileishmanial activity and QSAR studies of 2-chloro- N -arylacetamides”, Braz. J. Pharm. Sci., vol. 53, no. 1, p. e16067-, Jan. 2017, doi: 10.1590/s2175-97902017000116067.